相关实验视频
Updated: Jan 12, 2026

08:44
Activating Autophagy by Aerobic Exercise in Mice
Published on: February 3, 2017
12.7K
有氧运动和肠道菌群:在患有帕金森病的小鼠中改善认知障碍的关键联系
Wen Peng Shan1, Shi Lei Yan2, Yuan Yuan Guo2
1Public Experiment Platform, Xuzhou Medical University, Xuzhou, China.
Frontiers in aging neuroscience
|November 6, 2025
概括
有氧运动改善了帕金森病 (PD) 的小鼠的肠道微生物群平衡,缓解了认知缺陷. 肠道微生物通过通过PGC1-α/CREB调节FNDC5分泌来调节这些神经保护作用.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 运动生理学 运动生理学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特点是运动和认知能力下降.
- 肠道微生物群不平衡越来越多地与PD病变发生有关,这表明了新的治疗点.
- 肠道微生物群在调解有氧运动对PD认知障碍的益处中的作用需要进一步调查.
研究的目的:
- 探索有氧运动改善PD患者认知障碍的机制.
- 研究肠道微生物群结构的调节及其对PD认知功能的影响.
- 为针对肠道微生物群的新型PD治疗策略提供理论基础.
主要方法:
- 利用MPTP诱导的PD小鼠模型来评估长期有氧运动的影响.
- 采用16S rRNA基因测序和代谢学来分析肠道微生物群和血代谢物.
- 进行行为,形态和分子生物学分析,包括抗生素治疗实验.
主要成果:
- 有氧运动减轻了PD小鼠的病理障碍和认知缺陷,促进了FNDC5和BDNF分泌.
- 观察到肠道微生物群组成的显著变化,有益细菌的丰富性增加,有害细菌减少.
- 肠道菌群通过PGC1-α/CREB通路调节FNDC5分泌来调节有氧运动的神经保护作用.
结论:
- 有氧运动通过改善肠道菌群不平衡来改善PD病理和认知缺陷.
- 肠道微生物群在调解有氧运动在PD中的神经保护作用方面发挥着至关重要的作用.
- 抗生素治疗可以抵消有氧运动对非运动症状的益处,突出显示肠道菌群的重要性.
相关概念视频
Parkinson's Disease: Treatment
954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

